PROBLEM TO BE SOLVED: To provide a novel compound that can be used as a selective mineralocorticoid receptor antagonist for treating disorders in particular cardiovascular disorders, and a medicament containing said compounds for the treatment and/or prevention of aldosteronism, hypertension, chronic heart failure, sequelae of myocardial infarction, liver cirrhosis, renal failure, stroke, diabetes mellitus or diabetic sequelae.SOLUTION: Provided are novel 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides having the following formula wherein D denotes CH. Methods for producing the same is also provided.【課題】障害、特に心血管障害の処置用の、選択的鉱質コルチコイド受容体アンタゴニストとして使用できる新規化合物、および該化合物を含むアルドステロン症、高血圧、慢性心不全、心筋梗塞の後遺症、肝硬変、腎不全、卒中、真性糖尿病または糖尿病性続発症の処置および/または予防用の医薬の提供。【解決手段】下式でDがCHを表す、新規4-アリール-1,4-ジヒドロ-1,6-ナフチリジン-3-カルボキサミド類。これらの製造方法にも関する。【選択図】なし